Fixed Versus Flexible Gonadotropin-releasing Hormone (GnRH) Antagonist Initiation
NCT ID: NCT01005784
Last Updated: 2009-11-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
146 participants
INTERVENTIONAL
2005-06-30
2008-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Agonist Gonadotropin-Releasing Hormone (GnRH) Versus Antagonist GnRH
NCT00823602
GnRH Antagonist for Treatment of Early Ovarian Hyperstimulation Syndrome
NCT01268761
Gonadotropin-releasing Hormone Antagonist on Triggering Day: A Randomized Controlled Study
NCT00571870
Pregnancy Outcomes With a GnRH Antagonist Protocol Versus GnRH-Agonist Protocol in ICSI Cycles
NCT00485537
Ovarian Stimulation With FSH Alone Versus FSH Plus GnRH Antagonist in an Oocyte Donor/Recipient Programme
NCT05759871
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
fixed
Cetrorelix (Cetrotide)
fixed antagonist administration on day 6 of ovarian stimulation
flexible
Cetrorelix (Cetrotide)
flexible antagonist administration according to specified criteria
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cetrorelix (Cetrotide)
flexible antagonist administration according to specified criteria
Cetrorelix (Cetrotide)
fixed antagonist administration on day 6 of ovarian stimulation
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI 18.5-29.9
* \<= 3 previous IVF cycles
Exclusion Criteria
* Endometriosis
18 Years
39 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aristotle University Of Thessaloniki
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Medical School, Aristotle University of Thessaloniki
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Efstratios Kolibianakis
Role: PRINCIPAL_INVESTIGATOR
Unit for Human Reproduction
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Unit for Human Reproduction
Thessaloniki, , Greece
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kolibianakis EM, Venetis CA, Kalogeropoulou L, Papanikolaou E, Tarlatzis BC. Fixed versus flexible gonadotropin-releasing hormone antagonist administration in in vitro fertilization: a randomized controlled trial. Fertil Steril. 2011 Feb;95(2):558-62. doi: 10.1016/j.fertnstert.2010.05.052. Epub 2010 Jul 16.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UHR-3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.